# Cardiac tumors

Condition · id `cardio:cardiac-tumors` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Heart neoplasms; Heart tumors

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

Cardiac tumors are tumors in any part of the heart. MeSH says they include primary cardiac tumors and metastatic tumors to the heart, and that by interfering with normal heart function they can cause symptoms including heart failure, heart rhythm problems or embolism. A 2024 review says cardiac tumors are rare, that most are asymptomatic and found incidentally, and that treatment options and outlook depend on the subtype, the size of the tumor and where it is.

## Technical summary

MeSH Heart Neoplasms (D006338, exact): Cardiac Tumors is an entry term of the descriptor's preferred concept (term T682178 in the concept record M0009959, term lookup on 2026-11-18). The description rests on the MeSH scope note and on a 2024 review under a CC BY licence (Brazilian Journal of Cardiovascular Surgery). The review's prevalence figures, tumor types, imaging methods and survival data are not repeated here. The evidence is descriptive and comes from a narrative review, with no trial data.

## Claims, with the population each applies to

## Context: People with tumors of the heart (narrative review)

Recipient: Recipient not specified; Population: People with primary or metastatic tumors of the heart, as the review describes them. The review also discusses benign and malignant tumors separately.; Care setting: Clinical and surgical care, as described in the review.; Geography: Not stated for the review as a whole.; Life stage: Not restricted by the source. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a condition).

### MeSH describes cardiac tumors as tumors in any part of the heart, including primary cardiac tumors and metastatic tumors to the heart, whose interference with normal cardiac function can cause symptoms including heart failure, cardiac arrhythmias or embolism. A 2024 narrative review (Brazilian Journal of Cardiovascular Surgery) says cardiac tumors are rare and encompass a variety of presentations, that the majority are asymptomatic and found incidentally, and that treatment options and prognosis vary highly depending on the subtype, tumor size and location. It says surgical resection is usually the first-line therapy, except for cardiac lymphomas.

- Category: Description
- Evidence stage: Evidence synthesis
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: People with primary or metastatic tumors of the heart, as the review describes them. The review also discusses benign and malignant tumors separately.; Care setting: Clinical and surgical care, as described in the review.; Geography: Not stated for the review as a whole.; Life stage: Not restricted by the source. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a condition).
- Limitations: A narrative review and a thesaurus scope note, with no study data. The review's prevalence figures, tumor types, imaging methods and survival data are not repeated. The statement about surgery is what the review says in its abstract, not advice on treatment or on who should have an operation.
- Last checked: 2026-11-18
- Sources:
  1. Supports: MeSH scope note for descriptor D006338 (Heart Neoplasms) (Dataset, edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0009959>
     Locator: scopeNote.@value, sentence 1. Retrieved 2026-11-18T18:06:15Z. Source state: Current. Version fingerprint: ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e.
     How it applies: MeSH scope note: tumors in any part of the heart.
  2. Supports: MeSH scope note for descriptor D006338 (Heart Neoplasms) (Dataset, edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0009959>
     Locator: scopeNote.@value, sentence 2. Retrieved 2026-11-18T18:06:15Z. Source state: Current. Version fingerprint: ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e.
     How it applies: MeSH scope note: primary and metastatic tumors.
  3. Supports: MeSH scope note for descriptor D006338 (Heart Neoplasms) (Dataset, edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0009959>
     Locator: scopeNote.@value, sentence 3. Retrieved 2026-11-18T18:06:15Z. Source state: Current. Version fingerprint: ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e.
     How it applies: MeSH scope note: symptoms can include heart failure, arrhythmias or embolism.
  4. Supports: Cardiac Tumors: Review (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC11262154/>
     Locator: Abstract, sentence 1. Retrieved 2026-11-18T18:09:58Z. Source state: Current. Version fingerprint: 8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899.
     How it applies: Cardiac tumors are rare.
  5. Supports: Cardiac Tumors: Review (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC11262154/>
     Locator: Introduction, para 2, sentence 1. Retrieved 2026-11-18T18:09:58Z. Source state: Current. Version fingerprint: 8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899.
     How it applies: Most are asymptomatic and found incidentally.
  6. Supports: Cardiac Tumors: Review (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC11262154/>
     Locator: Abstract, sentence 3. Retrieved 2026-11-18T18:09:58Z. Source state: Current. Version fingerprint: 8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899.
     How it applies: Treatment and prognosis vary with subtype, size and location.
  7. Supports: Cardiac Tumors: Review (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC11262154/>
     Locator: Abstract, sentence 4. Retrieved 2026-11-18T18:09:58Z. Source state: Current. Version fingerprint: 8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899.
     How it applies: The review says surgical resection is usually first-line except for lymphomas.

## Connected pages

- Filed under this front: Procedures and surgery (`cardio:front-procedures-and-surgery`)
- MeSH names heart failure among the symptoms cardiac tumors can cause: Heart failure (`cardio:heart-failure`)
- MeSH names cardiac arrhythmias among the symptoms cardiac tumors can cause: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)

## Provenance

Content hash: c13287363165226c0844cdee75a96eeff8d0b8f92b598ec2a993d850b01ef31b
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
